Start-Up Previews (07/2007)
A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Start-Ups in Obesity," "New Technologies for Infertility," and "New Zealand Biotech." Plus these Start-Ups Across Health Care: Intelect Medical, N Spine, and Solace Pharmaceuticals.
You may also be interested in...
GlaxoSmithKline's diabetes drug Avandia survived a perilous FDA advisory committee review. The real question is whether the industry can survive the damage to FDA's credibility.
The success rates for in vitro fertilization are rather low--about 34%--and although this isn't much worse than the odds that nature offers for getting pregnant, for the couple that has elected to undergo IVF this risk-benefit proposition is difficult to bear. Molecular Biometrics helps to improve the outcomes of IVF with a diagnostic that determines embryo health.
Intelect Medical brings together a patent portfolio from the Cleveland Clinic and Cornell's Weill Medical College, and a management team experienced in neuromodulation, to usher in a new generation of deep brain stimulation. The start-up's initial target markets are traumatic brain injury and stroke.